Skip to main content

Table 4 Functional outcome after HIFU treatment (mean(SD))

From: Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer

 

Pre - HIFU

Post - HIFU

Continence and micturation symptoms

 IPSS – Score

10.9 (7.1)

9.2 (6.2)

 Micturation volume (ml)

207.7 (116.5)

189.2 (92.4)

 Post voiding Residual volume(ml)

45.5 (69.4)

54.0 (93.6)

 Qmax (ml/sec)

14.0 (8.2)

14.1 (8.7)

 Continence

  Continent

93 (88.6%)

71 (67.6%)

  Incontince grade I°

5 (4.8%)

20 (19.0%)

  Incontince grade II°

0 (0.0%)

3 (2.9%)

  Incontince grade III°

1 (1.0%)

1 (1.0%)

  Urge incontinence

6 (5.7%)

10 (9.5%)

 Pad usage

  No pads

102 (97.1%)

86 (81.9%)

  1 pad

1 (1.0%)

10 (9.5%)

  2 pads

1 (1.0%)

7 (6.7%)

   > 2 pads

1 (1.0%)

2 (1.9%)

Sexual function

 Sexual intercourse after HIFU

  Yes

 

36 (35.6%)

  No

 

65 (64.4%)

   Due to HIFU treatment

 

46 (45.5%)

   Other reason

 

55 (54.5%)

IIEF – 5

IIEF - 5 – score

17.2 (7.3)

9.7 (8.0)

 IIEF - 5 - non – nervesparing

15.1 (8.1)

7.5 (7.4)

 IIEF - 5 - onesided - nervesparing

19.7 (4.8)

12.5 (8.3)

 IIEF - 5 - bothsided – nervesparing

20.7 (5.3)

12.1 (7.5)